chr4-16166623-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_153365.3(TAPT1):c.1474+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0248 in 1,611,980 control chromosomes in the GnomAD database, including 577 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 48 hom., cov: 32)
Exomes 𝑓: 0.025 ( 529 hom. )
Consequence
TAPT1
NM_153365.3 intron
NM_153365.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0830
Genes affected
TAPT1 (HGNC:26887): (transmembrane anterior posterior transformation 1) This gene encodes a highly conserved protein that localizes to the centrosome and/or ciliary basal body. Mutations in this gene disrupt Golgi morphology and trafficking and normal primary cilium formation and these mutations are congenitally manifested by severe undermineralization of the intra-uterine skeleton. A mutation in the mouse ortholog of this gene results in homeotic, posterior-to-anterior transformations of the axial skeleton which are similar to the phenotype of mouse homeobox C8 gene mutants. In mouse, this gene is thought to function downstream of homeobox C8 to transduce extracellular patterning information during axial skeleton development. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 4-16166623-C-T is Benign according to our data. Variant chr4-16166623-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1207054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-16166623-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0214 (3257/152276) while in subpopulation AMR AF= 0.0268 (410/15300). AF 95% confidence interval is 0.0247. There are 48 homozygotes in gnomad4. There are 1516 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 48 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAPT1 | NM_153365.3 | c.1474+10G>A | intron_variant | ENST00000405303.7 | NP_699196.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAPT1 | ENST00000405303.7 | c.1474+10G>A | intron_variant | 1 | NM_153365.3 | ENSP00000385347.2 |
Frequencies
GnomAD3 genomes AF: 0.0214 AC: 3249AN: 152158Hom.: 47 Cov.: 32
GnomAD3 genomes
AF:
AC:
3249
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0222 AC: 5534AN: 249028Hom.: 77 AF XY: 0.0221 AC XY: 2984AN XY: 135098
GnomAD3 exomes
AF:
AC:
5534
AN:
249028
Hom.:
AF XY:
AC XY:
2984
AN XY:
135098
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0251 AC: 36680AN: 1459704Hom.: 529 Cov.: 31 AF XY: 0.0249 AC XY: 18081AN XY: 725772
GnomAD4 exome
AF:
AC:
36680
AN:
1459704
Hom.:
Cov.:
31
AF XY:
AC XY:
18081
AN XY:
725772
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0214 AC: 3257AN: 152276Hom.: 48 Cov.: 32 AF XY: 0.0204 AC XY: 1516AN XY: 74450
GnomAD4 genome
AF:
AC:
3257
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
1516
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 09, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at